Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-01 @ 7:14 PM
Study NCT ID:
NCT06751251
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-10
First Post:
2024-12-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination
Sponsor:
Peking University People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-20
First Submit QC Date:
None
Study First Post Date:
2024-12-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-05
Last Update Post Date:
2025-07-10
Last Update Post Date Type:
ACTUAL